key: cord-0779024-gono5ow3 authors: Odieka, Anwuli Endurance; Obuzor, Gloria Ukalina; Oyedeji, Opeoluwa Oyehan; Gondwe, Mavuto; Hosu, Yiseyon Sunday; Oyedeji, Adebola Omowunmi title: The Medicinal Natural Products of Cannabis sativa Linn.: A Review date: 2022-03-04 journal: Molecules DOI: 10.3390/molecules27051689 sha: dad917de4cb042ee7e2a3b7670b147c40830a73c doc_id: 779024 cord_uid: gono5ow3 Cannabis sativa is known among many cultures for its medicinal potential. Its complexity contributes to the historical application of various parts of the plant in ethno-medicines and pharmacotherapy. C. sativa has been used for the treatment of rheumatism, epilepsy, asthma, skin burns, pain, the management of sexually transmitted diseases, difficulties during child labor, postpartum hemorrhage, and gastrointestinal activity. However, the use of C. sativa is still limited, and it is illegal in most countries. Thus, this review aims to highlight the biological potential of the plant parts, as well as the techniques for the extraction, isolation, and characterization of C. sativa compounds. The plant produces a unique class of terpenophenolic compounds, called cannabinoids, as well as non-cannabinoid compounds. The exhaustive profiling of bioactive compounds and the chemical characterization and analysis of C. sativa compounds, which modern research has not yet fully achieved, is needed for the consistency, standardization, and the justified application of Cannabis sativa products for therapeutic purposes. Studies on the clinical relevance and applications of cannabinoids and non-cannabinoid phenols in the prevention and treatment of life-threatening diseases is indeed significant. Furthermore, psychoactive cannabinoids, when chemically standardized and administered under medical supervision, can be the legal answer to the use of C. sativa. The applications of plants as medicines predates human history. A medicinal plant refers to any plant which contains substances of therapeutic potential in one or more of its parts for the synthesis of plant-based drugs [1] . Active medicinal plant ingredients are referred to as bioactive phytochemicals. [2] . These bioactive compounds are believed to increase the ability of plants to survive or adapt to their surroundings [3] and are used as medicines, flavorings, and recreational drugs in humans. One notable medicinal plant that has continued to garner attention over the years, and in recent times, is Cannabis sativa. Cannabis sativa L. is known for its medicinal uses since ancient times, because of its rich supply of phytochemicals [4] , hence the quest for harnessing its pharmacological potential by scientists. The term "Cannabis" is used to define the products (drugs and essential oils) that are prepared or obtained from the annual herb C. sativa and its variants, which are of the family Cannabaceae [5] . The utilization of this multipurpose plant has been restrained for a long time because of the psychoactive effects of a specific cannabinoid Despite the influx of chemical-based medicines for treatments, the relevance of medicinal plants in drug development cannot be overemphasized. In recent years, commercial medicinal cannabis products with several variations in the phytocannabinoid content have been licensed and produced in Canada [7, 8] and in several other countries. Several synthetic and standardized products are currently available on the market; however, patients' preferences lean towards herbal preparations, because they are easy to handle and selfadminister [7] . Thus, this review intends to highlight the phytochemicals present in the different plant parts, which potentiates their pharmacological activities, as well as the techniques for the extraction, isolation, and characterization of C. sativa compounds. Literature on the published works of Cannabis sativa was obtained using electronic search engines, such as Google Scholar, the WSU online database (PubChem), and Science Direct. The keywords included, namely, Cannabis sativa, medicinal plants, Cannabis phytochemicals, ethnopharmacology bioactivity, and medicinal potentials, were used to source for data. An extensive review of the literature from 2011 through to 2021 (the last ten years) on Cannabis sativa L. was used to summarize its medicinal potential. Conversely, an emphasis will be placed on the isolation and characterization techniques from 1970 to 2021 to have a broadened view of the advancements in analytical techniques over the past years. Overall, twenty-nine (29) papers relating to the areas of our focus were chosen and were reviewed by all authors. The results from the search were carefully sorted, based on a general understanding, the review questions, and the related objectives. The genus name Cannabis means "cane-like" while sativa means "sown", which signifies that the plant is propagated from the seed and not from the roots [12] . It is believed to have originated in Asia and occurs widely in Africa [12, 13] . Central and south-east Asia are the potential natural origins for the domestication of the Cannabis genus [14] and it is known by different common names in different languages (hemp, marihuana, kannabis sativa, ganja, bhang, and al-bhango) [15] . In South Africa, it is colloquially known, in Afrikaans, as "dagga"; in IsiXhoxa as "umfincafincane"; and in Isizulu as "umunyane" [16, 17] . Taxonomically, Carl Linnaeus, a Swedish botanist, was the first to coin the name Cannabis sativa [18] . Other botanists stated that different types of Cannabis existed based on their size, shape, and resin content (breeding and selection). This review discusses, in particular, C. sativa. The Cannabis phenotype (its observable traits or characteristics, such as its leaf shape and flower color) is based on two main factors: its genetic code (genotype) and the external environmental factors [19] . The roots are branched and are about 30-60 cm deep (Farag and Kayser, 2017) [12] . Cannabis inflorescence is made up of several flower heads found on long leafy stems from each leaf axil. A single brownish fruit, about 2-5mm long, is produced per flower, and it contains a single seed tightly covered with a hard shell [12] . The fruit is propagated by bird and the seed germinates after 8-12 days [18] . The leaves, bracts, and stems of the plant are rich in trichrome, which are a diverse set of structures containing the secondary metabolites (phytocannabinoids and terpenoids) responsible for the defense, plant interactions, and typical smell [18] . Figure 1 , below, shows the plant parts of C. sativa. Cannabis, as a herbal medicine, is a complex mixture of compounds, including cannabinoid phenols, non-cannabinoid phenols (stilbenoids, lignans, spiro-indans, and dihydrophenanthrenes), flavonoids, terpenoids, alcohols, aldehydes, n-alkanes, wax esters, steroids, and alkaloids [6, 8, 11] . Over 500 chemical compounds have been isolated from the cannabis plant and have been reported [13] . The several classes of secondary metabolites are present in different parts of the plant with a wide range of applications (nutraceuticals, cosmetics, aromatherapy, and pharmacotherapy) that are beneficial for humans. However, previous studies have focused mainly on the cannabinoids, Δ 9 -tetrahydrocannabinol (Δ 9 -THC) and cannabidiol (CBD) in particular; hence, the female flower top is only harvested, while other parts of the plant are discarded [11] . Cannabinoids are a class of terpenophenolic compounds obtained by the alkylation of an alkyl-resorcinol with a monoterpene unit [20, 21] . They feature alkyl resorcinol and monoterpene moieties in their molecules [20, 22] . This specific chemical class in Cannabis is present in the glandular trichomes, which are abundant in the female flower as phytocannabinoid acids, and in the vegetable matrix as neutral phytocannabinoids [6, 13] . They are biosynthesized by the alkylation of olivetolic acid with geranyl-pyrophosphate by a prenyltransferase to produce cannabigerolic acid (CBGA). Decarboxylation, a chemical reaction, converts the acidic forms (Δ 9 THCA, CBDA, CBCA, and CBGA) into their neutral forms, which are more active and efficient in terms of pharmacological activity [8, 23] . To date, 125 cannabinoids have been identified and reported, in addition to five new cannabinoids reported in the past two years, 42 non-cannabinoid phenolics, 34 flavonoids, 120 terpenoids, 3 sterols, and 2 alkaloids [8, 11, 13] . Terpenoids are the second largest class of cannabis compounds and are responsible for their characteristic aroma [13] . Table 1 below summarizes the classes of compounds isolated from Cannabis sativa and the different plant parts in which they are present. Cannabis, as a herbal medicine, is a complex mixture of compounds, including cannabinoid phenols, non-cannabinoid phenols (stilbenoids, lignans, spiro-indans, and dihydrophenanthrenes), flavonoids, terpenoids, alcohols, aldehydes, n-alkanes, wax esters, steroids, and alkaloids [6, 8, 11] . Over 500 chemical compounds have been isolated from the cannabis plant and have been reported [13] . The several classes of secondary metabolites are present in different parts of the plant with a wide range of applications (nutraceuticals, cosmetics, aromatherapy, and pharmacotherapy) that are beneficial for humans. However, previous studies have focused mainly on the cannabinoids, ∆ 9 -tetrahydrocannabinol (∆ 9 -THC) and cannabidiol (CBD) in particular; hence, the female flower top is only harvested, while other parts of the plant are discarded [11] . Cannabinoids are a class of terpenophenolic compounds obtained by the alkylation of an alkyl-resorcinol with a monoterpene unit [20, 21] . They feature alkyl resorcinol and monoterpene moieties in their molecules [20, 22] . This specific chemical class in Cannabis is present in the glandular trichomes, which are abundant in the female flower as phytocannabinoid acids, and in the vegetable matrix as neutral phytocannabinoids [6, 13] . They are biosynthesized by the alkylation of olivetolic acid with geranyl-pyrophosphate by a prenyltransferase to produce cannabigerolic acid (CBGA). Decarboxylation, a chemical reaction, converts the acidic forms (∆ 9 THCA, CBDA, CBCA, and CBGA) into their neutral forms, which are more active and efficient in terms of pharmacological activity [8, 23] . To date, 125 cannabinoids have been identified and reported, in addition to five new cannabinoids reported in the past two years, 42 non-cannabinoid phenolics, 34 flavonoids, 120 terpenoids, 3 sterols, and 2 alkaloids [8, 11, 13] . Terpenoids are the second largest class of cannabis compounds and are responsible for their characteristic aroma [13] . Table 1 below summarizes the classes of compounds isolated from Cannabis sativa and the different plant parts in which they are present. Leaves, flowers, resin, stembarks, and roots ∆ 9 -tetrahydrocannabivarin, α/β-fenchyl ∆ 9 -tetrahydrocannabinolate, ∆ 9 -tetrahydrocannabinol, α-terpenyl (−)-∆ 9 -trans-tetrahydrocannabinolate, γ-eudesmyl (−)∆ 9 -trans-tetrahydrocannabinolate, 8α-hydroxy-(−)-∆ 9 -transtetrahydrocannabinol, 8b-hydroxy-(−)-∆ 9 -trans-tetrahydro cannabinol, 8-oxo-(−)-∆ 9 -trans-tetrahydrocannabinol, Cannabisol, (−)-∆ 9 -trans-tetrahydrocannabiphorol, (−)-∆ 9 -trans-tetrahydrocannabihexol, (−)-∆ 8 α-pinene, β-pinene, linalool, linalool oxide, myrcene, limonene, camphene, α-terpinene, γ-terpinene, α-terpinolene, α-terpineol, terpinene-4-ol, sabinene, sabinene hydrate, cis-sabinene hydrate, α-phellandrene, β-phellandrene, 2-methyl-2-heptene-6-one, borneol, piperitenone, geraniol, carvacrol, carvone, cis-carveol, citronellol, bornyl acetate, ipsdienol, germacrene-B, clovandiol, α-bisabolol, β-eudesmol, γ-eudesmol, α-caryophyllene, β-caryophyllene oxide, α-Humulene, Phytol, neophytadiene, friedelin (friedelan-3-one), epifriedelanol, β-amyrin, Vomifoliol, dihydrovomifoliol, and dihydroactinidiolide β-ionone Many methods have been reported for the extraction of Cannabis in the literature. These include direct maceration (DM), soxhlex extraction, ultrasound-assisted extraction (UAE), supercritical fluid extraction, and microwave-assisted extraction (MAE) [41] . However, two methods of extracting Cannabis are differentiated in the literature [41] . The first is the maceration of the plant material in an organic solvent (direct maceration) and the subsequent removal of the solvent by the concentration of the extract under reduced pressure [41] . The second is the innovative supercritical fluid extraction (SFE) method, which involves the use of pressurized solvents [41] . It is necessary for cannabinoid compounds to be extracted with organic solvents instead of water, because the active compounds are less soluble in polar solvents [41] . The most commonly used solvents are ethanol, ether, chloroform, and methanol [42] . When used for extraction, various compounds, including some undesired substances, dissolve together with the cannabinoids [42] . The high solvent power of ethanol for cannabinoid compounds is the reason why it is frequently used in home-made extracts of Cannabis [41] . However, non-desired compounds (chlorophyll, lipids, and waxy materials) are also extracted which, therefore, requires further steps to remove the co-extracted impurities for a high-purity medicinal product to be obtained [41] . A patent on the method for the isolation of herbal and cannabinoid medicinal extracts stated that the solubility of non-therapeutic substances (chlorophyll and waxy materials) is reduced when the solvent is selected from a group that includes acetonitrile, benzene, dichloromethane, diethyl ether, acetone, butanol, ethanol, chloroform, ethyl acetate, hexane, pentane, propanol, tetrahydrofuran, toluene, xylene, and various combinations of these solvents [41] . The International Conference on Harmonization (ICH) recommends the use of less toxic solvents in the manufacture of drug substances and dosage forms, and sets pharmaceutical limits for residual solvents in drug products [43] . Residual solvents pose risks to human health and are classified into three classes. Class 1 solvents (including carbon tetrachloride, benzene, and methyl chloroform) are regarded as human carcinogens and are environmentally hazardous [41] . Class 2 solvents include methanol and hexane, which are generally said to be limited, and they are possible causative agents of irreversible toxicity, such as neurotoxicity or teratogenicity [41] . Class 3 solvents (ethanol and ethyl acetate) are generally regarded as having a low toxic potential to humans [41] ). Above all, ethanol is generally recognized as a safe (GRAS) solvent [41] . In a study by Brighenti et al., they compared the following four extraction techniques to obtain a high yield of medicinal cannabinoids: ultrasound-assisted extraction (UAE), microwave-assisted extraction (MAE), supercritical fluid extraction (SFE), and direct maceration (DM). They concluded that DM, with ethanol as the extraction solvent at room temperature for an overall time of 45 min, is the best extraction technique (in terms of a high yield) for non-psychoactive cannabinoids from hemp [44] . Over the last decade, compounds in Cannabis have been identified, isolated, and determined by various chromatographic techniques with different spectroscopic detection methods. C. sativa samples are analyzed for both legal and medicinal purposes [41] . Nevertheless, the knowledge of their exact composition remains very significant. In 2009, recommended methods for the identification and analysis of cannabis products were released by the United Nations Office on Drugs and Crime [45] . One notable technique that has been employed in identifying the diverse composition of the compounds found is highperformance liquid chromatography (HPLC) [41] . Spectroscopic approaches or methods are based on the variable absorbance or redirection of electromagnetic (EM) radiation by chemical bonds, resulting in the radiation or transition of the sample's atoms to a higher energy state [46] . Some advantages are attributed to these spectroscopic methods, such as permitting spatial measurements of metabolites and offering a global metabolic fingerprint of a sample with rapid spectral acquisition [46] . Some of these approaches/methods include Fourier transform infrared spectroscopy (FTIR), nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), HPLC, gas chromatography-mass spectrometry (GC-MS), and liquid chromatography-mass spectrometry (LS-MS) [41, 46] . Taking into account the recommended methods and the mandatory requirement of the Ministerial decree to use only chromatographic techniques coupled with mass spectrometric detection, cannabinoid concentrations and its stability in cannabis tea and cannabis oil, prepared from standardized flowering tops obtained from the Military Pharmaceutical Chemical Works of Florence, were studied by Pacifici et al. using easy and fast ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) [9, 10] . Table 2 is a summary of the reported extraction solvents, as well as the identification, isolation, and characterization methods of Cannabis. α-terpenyl ∆ 9 -tetrahydrocannabinolate, 4-terpenyl ∆ 9 -tetrahydro-cannabinolate, α-cadinyl ∆ 9 -tetrahydrocannabinolate, γ-eudesmyl ∆ 9 -tetrahydro-cannabinolate, γ-eudesmyl cannabigerolate, 4-terpenyl cannabinolate, bornyl ∆ 9 -tetrahydrocannabinolate, α-fenchyl ∆ 9 -tetrahydro-cannabinolate, α-cadinyl cannabigerolate, ∆ 9 -tetrahydro-cannabinol (∆ 9 -THC), ∆ 9 -tetrahydrocannabinolic acid A (∆ 9 -THCA), Cannabinolic acid A (CBNA), and Cannabigerolic acid (CBGA), (±)-6,7-transepoxycannabigerolic acid, (+)-6,7-cis-epoxycannabigerolic acid, (±)-6,7-cis-epoxycannabigerol, 5 -Methoxy-cannabigerolic acid, 5 -methyl-4-pentylbiphenyl-2, 2 , 6-triol,7-methoxy-cannabispirone, (±)-6,7-trans-epoxycannabigerol, 8α-hydroxy-(−)-∆ 9 -transtetrahydrocannabinol, 8b-hydroxy-(−)-∆ 9 -trans-tetrahydro cannabinol, 8-oxo-(−)-∆ 9 -transtetrahydrocannabinol, 10α-hydroxy-∆ 8 -tetrahydrocannabinol, 10β-hydroxy-∆ 8 -tetra-hydrocannabinol, 10a-α-hydroxy-10-oxo-∆ 8tetrahydrocannabinol, (±)-4-acetoxycannabichromene, (±)-3"-hydroxy-∆(4", 5")-cannabichromene,(−)-7hydroxycannabichromane,(−)-7 R-cannabicoumarononic acid A, 5-acetyl-4-hydroxycannabigerol, 4-acetoxy-2-geranyl-5-hydroxy-3n-pentylphenol, 8-hydroxycannabinol, 8-hydroxycannabinolic acid A, and 2-geranyl-5-hydroxy-3-npentyl-1, 4-benzoquinone, (±)-4-acetoxycannabichromene, (±)-3"-hydroxy-∆ 4 "-cannabichromene, (-)-7-hydroxycannabichromane, 8 and semi-synthesis β-cannabispiranol, b-cannabispirol, 5-hydroxy-7-methoxyindan-1spiro-cyclohexane, 7-hydroxy-5-methoxyindan-1spiro-cyclohexane, and 5,7-dihydroxyindan-1-spirocyclohexane, Cannabispirketal and the glycoside, a-cannabispiranol-4 -O-βglucopyranose, 3,4 ,5-trihydroxy-dihydrostilbene, 4,5-dihydroxy-2,3,7-trimethoxy-9,10-dihydrophenanthrene, 4-hydroxy-2,3,6,7-tetramethoxy-9,10-dihydrophenanthrene and 4,7-dimethoxy-1,2,5trihydroxyphenanthrene, Rutin, friedelin (friedelan-3-one) and epifriedelanol, Anhydrocannabisativine and cannabisativine, α,α -dihydro-3 ,4,5 -trihydroxy-4 -methoxy-3-isopentenylstilbene, α,α -dihydro-3,4 ,5-trihydroxy-4methoxy-2,6diisopentenylstilbene, α,α -dihydro-3 ,4,5 -trihydroxy-4 -methoxy-2 ,3diisopentenylstilbene, α,α -dihydro-3,4 ,5-trihydroxy-4,5 -diisopentenylstilbene, and combretastatin B-2 acetoxy-6-geranyl-3-n-pentyl-1,4benzoquinone, 4,5-dihydroxy-2,3,6-trimethoxy-9,10-dihydrophenanthrene, 4-hydroxy-2,3,6,7-tetramethoxy-9,10-dihydrophenanthrene, 4,7-dimethoxy-1,2,5trihydroxyphenanthrene, Cannflavin C and β-sitosteryl-3-O-β-Dglucopyranoside-2 -O-palmitate, α-cannabispiranol, Chrysoeriol, 6-prenylapigenin, and Cannflavin A and β-acetyl cannabispiranol [55] Hexane extract Leaves of Cannabis sativa Isolation by normal-phase chromatography followed by C 18 Canniprene, Cannabistilbene I and Cannabistibene II, and 2,3,5,6-tetramethoxy 9,10-dihydrophenanthrenedione [90] [91] [92] [93] [94] Mixture of hydro-alcoholic and organic solvents From the biological point of view, the psychoactive cannabinoids reported include ∆ 9 THC, cannabinol (CBN), and cannabinodiol (CBND), while cannabidiol (CBD) and other cannabinoids are non-psychoactive [8, 11] . THC is the major psychoactive component and the toxicity of this metabolite of Cannabis is the most studied [11, 28] . Its psychoactive component decreases in the order of inflorescence (the flower), leaves, stem, roots, and seeds, respectively [8] . The interest in the potential medical use of cannabis and cannabinoids rose significantly in the 1990s, following the discovery of the endocannabinoid (eCB) system in mammals [7] . The physiological effects of cannabinoids are exerted through various receptors, such as the cannabinoid receptors (CB1 and CB2), adrenergic receptors, and the recently discovered GPCRs (GPR 55 , GPR 3 and GPR 5 ) [8] . Historically, each part of the Cannabis plant is indicated mostly for pain killing, inflammation, and for mental illnesses. For example, the Cannabis root has been recommended for treating fever, inflammation, gout, arthritis, and joint pain, as well as skin burns, hard tumors, postpartum hemorrhage, difficult child labor, sexually transmitted diseases, gastrointestinal activity, and infections [40] . Cannabis has also been used to treat asthma, epilepsy, fatigue, glaucoma, insomnia, nausea, pain, and rheumatism, as well as being used as appetite stimulant and a digestive aid [7, 11, 13] . Since concentrations above 0.05% are pharmacologically interesting, Cannabis inflorescence and leaf material may contain sufficient cannabinoids, mono-and sesquiterpenoids, and flavonoids for therapeutic applications [11] . Cannabis terpenoids and flavonoids, mainly myrcene, limonene, pinene, β-caryophyllene, and cannflavin A, act in synergy with cannabinoids to induce pharmacological effects [7] . It was proven that these compounds, which are synthetized in the aerial parts of the plant, enhance CBD's anti-inflammatory effects and antagonize THC dysphoric action [96] . Cannabidiol (CBD) and Cannabidavarin (CBDV) (neutral cannabinoids) have been reported to have the therapeutic potential for the treatment of epilepsy (focal seizures), as well as treating nausea and vomiting [97, 98] . Conversely, THC and CBN have been found to be active in lowering intraocular pressure, and can be applied in all cases of glaucoma that are resistant to other therapies [9] . Cannflavin A and B are also notable flavonoids (prenylflavonoids) with medicinal potentials, such as their anti-inflammatory, anti-neoplastic, antioxidant, neuro-protective, anti-parasitic, and anti-viral effects [99] . Table 3 , below, shows a summary of the reported bioactivities (biological potentials) of the bioactive compounds present in Cannabis sativa. Table 3 . Summary of reported bioactivities associated with isolated compounds and essential oils from Cannabis sativa. Tetrahydrocannabinol THC Antioxidant, anti-pruritic, and anti-inflammatory effects [29, 100] Cannabidiol CBD Anti-convulsive, anti-inflammatory, immunosuppressive properties, antioxidant, and anti-psychotic effects [101] [102] [103] Cannabigerol CBG Anti-fungal effects, anti-cancer, anti-depressant, mild anti-hypertensive agent, analgesic, and antierythemic effects [29, 104] Cannabichromene CBC Anti-inflammatory and analgesic [29] Cannabinol CBN Sedative, anti-convulsant, anti-inflammatory, antibiotic, and anti-MRSA activity [29] Tetrahydrocannabivarin THCV Anti-convulsant [29] Tetrahydrocannabinolic acid THCA Immunomodulatory, anti-inflammatory, neuroprotective, anti-neoplastic activity, and antiemetic effects [29, 105] Cannabidavarin CBDV Anti-convulsant (anti-epileptic) properties and anti-emetic properties [106, 107] Cannabidiolic acid CBDA Anti-emetic effects [104, [108] [109] [110] β-Myrcene Anti-inflammatory and analgesic sedative agent [7, 29, 111] Strongly anxiolytic, anti-depressant, antibiotic, and anti-cancer agent [7, 29] β-Ocimene Anti-convulsant activity, anti-fungal activity, anti-tumor activity, and pest resistance [112, 113] γ-Terpinene Anti-inflammatory activity, antioxidant, and anti-proliferative activity [114, 115] α-Terpinene Antioxidant [29] α-Pinene Anti-inflammatory, bronchodilator, anti-microbial, and anxiolytic effects [7, 11, 29, 116] Linalool Analgesic and anticonvulsant, anxiolytic, anti-depressant, anti-glutamatergic, anti-leishmanial activity, anticancer agent, anti-nociceptive, and anti-depressant effects [111, [117] [118] [119] α-Phellandrene Anti-nociceptive, anti-depressant, anti-arthritic and allergic, and anti-hyperalgesic effects [120] [121] [122] Terpinolene Anti-fungal and larvicidal, anti-nociceptive, anti-inflammatory antioxidant, and anti-cancer effects [123, 124] β-Caryophyllene Cardio-protective, hepato-protective, gastro-protective, neuro-protective, nephro-protective, antioxidant, anti-inflammatory, anti-microbial, anti-pruritic, and immunomodulatory activities [7, [125] [126] [127] Caryophyllene Oxide Anti-fungal, insecticidal/anti-feedant, and antiplatelet effects [29] β-Elemene Anti-cancer and anti-tumor [128] Guaiol Anti-inflammatory, antioxidant, anti-cancer anti-rheumatic, antiseptic, diaphoretic, diuretic, and laxative effects [29, 129] Friedelin Anti-inflammatory, anti-pyretic, and antituberculosis agent [130, 131] Epifriedelanol Antioxidant [132] Cannflavin A and B Anti-inflammatory, neoplastic, antioxidant, neuroprotective, anti-parasitic, and anti-viral agent [4, 7, 29, 99] Apigenin Anxiolytic and estrogenic properties, anti-tumor, antioxidant, anti-inflammatory, anti-osteoporosis, and immune regulation effects [4, 133] Vitexin and Isovitexin Antioxidant, anti-cancer, anti-inflammatory, anti-diabetic, anti-microbial, anti-viral, anti-hyperalgesic, and neuroprotective effects [134] Quercetin Anti-cancer/anti-proliferator, antioxidative/anti-aging, anti-viral, anti-inflammatory, cardio-protective, skin-protective, anti-coagulant, and anti-platelet effects [135] Luteolin Neuroprotective effects, anti-inflammatory, and antioxidant effects [136] Lignans Antioxidant, anti-viral, anti-diabetic, anti-tumorigenic, and anti-obesity activities [4] Cannabis female flowering tops can be simply administered through commercially available vaporizers (e.g., Micro Vape, G Pen Herbal Vaporizer, and Volcano), buccal sprays (e.g., Sativex), oral capsules (e.g., Cannador), decoctions, or oils [7] . Only cannabis use through oral or inhalatory administration is allowed. Smoking reduces the bioavailability of cannabis ingredients by 40%, and its complete combustion can cause lung diseases and airway obstructions [7] . Homemade decoctions and pharmacy oils are currently the most widespread cannabis formulations in Europe, making the standardization of preparation difficult [7] . Cannabis pharmacological action is dose-dependent and can induce many adverse effects (AEs), principally related to THC, due to unintentional overdosing [7] . The typical symptoms of cannabis acute intoxication that have been reported are dizziness, confusion, tachycardia, postural hypotension, dysphoria, panic depression, hallucinations, allergic reactions, vomiting, and diarrhea [7, 137, 138] . Furthermore, withdrawal symptoms, such as irritability, aggression, anxiety, insomnia, decreased appetite, tremors, sweating, and headaches may appear after the abrupt cessation of the long-term administration of high doses of cannabis [7] . According to the ICH efficacy and safety guidelines, it is recommended to start with low doses and increase quantities after a satisfactory period of clinic evaluation, depending on the pharmacological effects and the possible adverse effects [139] . In the current COVID-19 pandemic, scientists are repurposing medicines (identifying new therapeutic use(s) of existing drugs) known for their biological potential (anti-viral or anti-inflammatory properties) to tackle the global issue and similar future viruses [140] . They have hypothesized that CBD could be used as an anti-viral agent [141] or antiinflammatory [142, 143] tool, or to inhibit pulmonary fibrosis in COVID-19 patients [144] . In addition, the known growing evidence of the anxiolytic effects of CBD have also been hypothesized to be used as a therapeutic option to treat long-lasting COVID-19-related anxiety and PTSD [145] , which is likely to be a significant issue of the pandemic. With the recent evaluation, acceptance, and legalization of Cannabis products for therapeutic purposes, researchers, particularly in the field of natural products, are challenged to improve and standardize the extraction and characterization of the bioactive compounds from Cannabis sativa. Despite various reports of its economic and therapeutic values, it is legal in a handful of jurisdictions (Uruguay, Canada, some US states, and parts of Africa). Presently, Cannabis remains illegal in several countries. This review summarized the biological potential and the techniques for the extraction, isolation, and characterization of Cannabis sativa compounds, and it describes the effectiveness of the various parts of the herb in pharmacotherapy. The usage of C. sativa roots and stem barks in present-day medical research, and the development of new Cannabis-based medicines or products, in contrast to the flowering part only, is highly recommended because they can be exploited for medicine and other uses. In addition, Cannabis-based pharmaceutical products must undergo long purification processes to eliminate unwanted components such as chlorophyll and residual organic solvents. The use of standardized reagents is also very crucial in the analytical studies of C. sativa. Furthermore, future research should seek to clarify the factors responsible for the complexity of C. sativa extracts in terms of their chemical compositions, the physical properties of their active ingredients, and their liability to photochemical oxidation. The role and place of medicinal plants in the strategies for disease prevention Variation in preliminary phytochemicals screening of Cannabis sativa L. leaf, stem and root Techniques for the extraction of bioactive compounds from Lebanese Urtica Dioica Cannabis sativa: The plant of the thousand and one molecules Phytochemistry of Cannabis sativa L Supercritical fluid technologies applied to the extraction of compounds of industrial interest from Cannabis sativa L. and to their pharmaceutical formulations: A review Herbal preparations of medical cannabis: A vademecum for prescribing doctors Chemical profiling of medical Cannabis extracts Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry Secondary metabolites profiled in cannabis inflorescences, leaves, stem barks, and roots for medicinal purposes The Cannabis plant: Botanical aspects Phenolics, Terpenes and Alkaloids of Cannabis. Molecules Between China and South Asia: A Middle Asian corridor of crop dispersal and agricultural innovation in the bronze age Cannabis sativa L.: Botany and horticulture A brief agricultural history of Cannabis in Africa, from prehistory to canna-colony Wild Cannabis": A review of the traditional use and phytochemistry of Leonotis leonurus Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history Phytocannabinoids: A unified critical inventory Cannabinoids: Occurrence and medicinal chemistry Phytocannabinoids as novel therapeutic agents in CNS disorders Extractions of medical Cannabis cultivars and the role of decarboxylation in optimal receptor responses Constituents of Cannabis sativa Cannabinoids and terpenes as chemotaxonomic markers in Cannabis Cannabis: From cultivar to chemovar II-A metabolomics approach to cannabis classification Genomic and chemical diversity in Cannabis Cannabis phenolics and their bioactivities Cannabis pharmacology: The usual suspects and a few promising leads Cannabis Inflorescence: Cannabis Spp.; Standards of Identity, Analysis, and Quality Control Isolation and pharmacological evaluation of minor cannabinoids from high-potency Cannabis sativa Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activity Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa Characterization of lignanamides from hemp (Cannabis sativa L.) seed and their antioxidant and acetylcholinesterase inhibitory activities Cannabis sativa L. inflorescences from monoecious cultivars grown in central Italy: An untargeted chemical characterization from early flowering to ripening Chemical and bioinformatics analyses of the anti-leishmanial and anti-oxidant activities of hemp essential oil Metabolomic profile and antioxidant/anti-inflammatory effects of industrial hemp water extract in fibroblasts, keratinocytes and isolated mouse skin specimens The united chemicals of Cannabis: Beneficial effects of cannabis phytochemicals on the brain and cognition Polyphenolic Compounds and antioxidant activity of cold-pressed seed oil from finola cultivar of Cannabis sativa L Cannabis roots: A traditional therapy with future potential for treating inflammation and pain. Cannabis Cannabinoid Res Extraction methods, analysis, and physicochemical characterization Extraction with environmentally friendly solvents International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Harmonised Guideline. Impurities: Guideline for Residual solventsq3c(R6) Development of a new extraction technique and hplc method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L.(hemp) Recommended Methods for the Identification and Analysis of Cannabis and Cannabis Products Metabolomic technologies and their application to the study of plants and plant-host interactions Development and validation of a fast gas chromatography/mass spectrometry method for the determination of cannabinoids in Cannabis sativa L Utilisation of design of experiments approach to optimise supercritical fluid extraction of medicinal Cannabis Qualitative and quantitative measurement of cannabinoids in Cannabis using modified hplc/dad method Cannabis: VII. Identification of cannabinol methyl ether from hashish Isolation and characterization of (+) cannabitriol and () 10 ethoxy 9 hydroxy delta 6a tetrahydrocannabinol: Two new cannabinoids from Cannabis sativa L. extract Cannabidiol monomethyl ether. A new neutral cannabinoid Minor oxygenated cannabinoids from high potency Cannabis sativa L Cannabinoid ester constituents from high-potency Cannabis sativa Non-cannabinoid constituents from a high potency Cannabis sativa variety Cannabitwinol, a dimeric phytocannabinoid from hemp, Cannabis sativa L.; is a selective thermo-TRP modulator A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than ∆ 9 Method of Preparing Delta-9 Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice Cannabisol, a novel ∆9-THC dimer possessing a unique methylene bridge, isolated from Cannabis sativa Characterization of the butyl homologues of D-1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of cannabis by combined gas chromotography and mass spectrometry Structural studies of cannabinoids. Theoretical and proton magnetic resonance analysis Chemical constituents of marijuana: The complex mixture of natural cannabinoids Propyl homologue of tetrahydrocannabinol: Its isolation from Cannabis, properties, and synthesis Isolation of two new cannabinoid acids from Cannabis sativa L. of Czechoslovak origin Cannabielsoic acids: Isolation and synthesis by a novel oxidative cyclization Identification in hashish of tetrahydrocannabinol, cannabidiol and cannabinol analogues with a methyl side-chain Nishioka, I. Cannabis. X. The isolation and structures of four new propyl cannabinoid acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid, from Thai Cannabis Cannabichromevarin and cannabigerovarin, two new propyl homologues of cannabichromene and cannabigerol A polar cannabinoid from Cannabis sativa Var. Carma Cannabis sativa L Cannabimovone, a cannabinoid with a rearranged terpenoid skeleton from hemp Cannabinerolic acid, a cannabinoid from Cannabis sativa Simple and straightforward analysis of cannabinoids in medicinal products by fast-GC-FID. Forensic Toxicol Impact of supercritical fluid extraction and traditional distillation on the isolation of aromatic compounds from Cannabis indica and Cannabis sativa The volatile oil composition of fresh and air-dried buds of Cannabis sativa Minor Components of Cannabis Resin: IV. Mass spectrometric data and gas chromatographic retention times of terpenic components with retention times shorter than that of cannabidiol Constituents of Cannabis sativa L. XVII. A review of the natural constituents Alkanes of the essential oil of Cannabis sativa Spiro-indans from Cannabis sativa Chemical constituents in hemp pectin I A new non-cannabinoid phenol from Cannabis sativa L. Experiential Chemical constituents of Cannabis sativa L. root Two new spiro-compounds, cannabispirol and acetyl cannabispirol Denbinobin, a naturally occurring 1, 4-phenanthrenequinone, inhibits HIV-1 replication through an NF-κB-dependent pathway Chemical investigation of Cannabis sativa leading to the discovery of a prenylspirodinone with anti-microbial potential Natural products of Thailand high ∆ 1-THC-strain Cannabis. the bibenzyl-spirandihydrophenanthrene group: Relations with cannabinoids and canniflavones Constituents of Cannabis sativa L. XXVIII. A review of the natural constituents Constituents of Cannabis sativa, XXV. Isolation of two new dihydrostilbenes from a panamanian variant X-ray structure of cannabispiran: A novel Cannabis constituent Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L A new 9, 10-dihydrophenanthrenedione from Cannabis sativa Cannabispirone and cannabispirenone, two naturally occurring spiro-compounds Phloroglucinol glucoside as a natural constituent of Cannabis sativa Terpenoids and phytocannabinoids co-produced in Cannabis sativa strains show specific interaction for ellcytotoxic activity Use of One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy Cannabinoids suppress acute and anticipatory nausea in preclinical rat models of conditioned gaping Cannflavins-From plant to patient: A scoping review Is lipid signaling through cannabinoid 2 receptors part of a protective system? Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial Regulation of nausea and vomiting by cannabinoids Cannabidiol for the prevention of graft-versus-host-disease after allogeneic hematopoietic cell transplantation: Results of a phase II study Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in S uncus murinus Effect of Phytocannabinoids on Nausea and Vomiting Can you pass the acid test? critical review and novel therapeutic perspectives of ∆9-tetrahydrocannabinolic acid A. Cannabis Cannabinoid Res Effect of low doses of cannabidiolic acid and ondansetron on licl-induced conditioned gaping (a model of nausea-induced behaviour) in rats Effect of combined oral doses of ∆ 9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects Tobacco overexpressing β-ocimene induces direct and indirect responses against aphids in receiver tomato plants Antitumour activity of the microencapsulation of Annona vepretorum essential oil Gamma-terpinene modulates acute inflammatory response in mice Antioxidant and antiproliferative properties of the essential oils of Satureja thymbra and Satureja parnassica and their major constituents Expression of BDNF and TH mRNA in the Brain Following Inhaled Administration of A-Pinene Linalool-incorporated nanoparticles as a novel anticancer agent for epithelial ovarian carcinoma Cannabis and epilepsy: An ancient treatment returns to the fore The current status of artisanal Cannabis for the treatment of epilepsy in the United States Antihyperalgesic and antidepressive actions of (R)-(+)-Limonene, A-phellandrene, and essential oil from schinus terebinthifolius fruits in a neuropathic pain model A-Phellandrene, a cyclic monoterpene, attenuates inflammatory response through neutrophil migration inhibition and mast cell degranulation Antinociceptive activity of the monoterpene α-phellandrene in rodents: Possible mechanisms of action Anticancer and antioxidant properties of terpinolene in rat brain cells Genotoxic and oxidative damage potentials in human lymphocytes after exposure to terpinolene in vitro The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice Research Paper Themed Issue B-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception one ingredient of a chinese herb, against malignant tumors: A literature-based meta-analysis −)-Guaiol Regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer Tuberculosis and nature's pharmacy of putative anti-tuberculosis agents Medicinal utilization of exotic plants by bapedi traditional healers to treat human ailments in Limpopo province, South Africa Epifriedelanol from the root bark of Ulmus davidiana inhibits cellular senescence in human primary cells Apigenin: A current review on its beneficial biological activities A review on the pharmacological effects of vitexin and isovitexin Therapeutic charm of quercetin and its derivatives: A review of research and patents The flavone luteolin improves central nervous system disorders by different mechanisms: A review Cannabidiol to improve mobility in people with multiple sclerosis Acute Cannabis Toxicity Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics Cannabinoids and the coronavirus Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment? SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation? The potential of cannabidiol in the COVID-19 pandemic Could cannabidiol be a treatment for coronavirus disease-19-related anxiety disorders? Cannabis Cannabinoid Res The authors declare no conflict of interest.